Drugs for Osteoarthritis Pain Market - Global Outlook and Forecast 2021-2027

Drugs for Osteoarthritis Pain Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Drugs for Osteoarthritis Pain Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Drugs for Osteoarthritis Pain Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Drugs for Osteoarthritis Pain Overall Market Size
2.1 Global Drugs for Osteoarthritis Pain Market Size: 2021 VS 2027
2.2 Global Drugs for Osteoarthritis Pain Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Drugs for Osteoarthritis Pain Players in Global Market
3.2 Top Global Drugs for Osteoarthritis Pain Companies Ranked by Revenue
3.3 Global Drugs for Osteoarthritis Pain Revenue by Companies
3.4 Top 3 and Top 5 Drugs for Osteoarthritis Pain Companies in Global Market, by Revenue in 2020
3.5 Global Companies Drugs for Osteoarthritis Pain Product Type
3.6 Tier 1, Tier 2 and Tier 3 Drugs for Osteoarthritis Pain Players in Global Market
3.6.1 List of Global Tier 1 Drugs for Osteoarthritis Pain Companies
3.6.2 List of Global Tier 2 and Tier 3 Drugs for Osteoarthritis Pain Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Drugs for Osteoarthritis Pain Market Size Markets, 2021 & 2027
4.1.2 Oral
4.1.3 Injection
4.1.4 External
4.2 By Type - Global Drugs for Osteoarthritis Pain Revenue & Forecasts
4.2.1 By Type - Global Drugs for Osteoarthritis Pain Revenue, 2016-2021
4.2.2 By Type - Global Drugs for Osteoarthritis Pain Revenue, 2022-2027
4.2.3 By Type - Global Drugs for Osteoarthritis Pain Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Drugs for Osteoarthritis Pain Market Size, 2021 & 2027
5.1.2 Medical Care
5.1.3 Personal Care
5.2 By Application - Global Drugs for Osteoarthritis Pain Revenue & Forecasts
5.2.1 By Application - Global Drugs for Osteoarthritis Pain Revenue, 2016-2021
5.2.2 By Application - Global Drugs for Osteoarthritis Pain Revenue, 2022-2027
5.2.3 By Application - Global Drugs for Osteoarthritis Pain Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Drugs for Osteoarthritis Pain Market Size, 2021 & 2027
6.2 By Region - Global Drugs for Osteoarthritis Pain Revenue & Forecasts
6.2.1 By Region - Global Drugs for Osteoarthritis Pain Revenue, 2016-2021
6.2.2 By Region - Global Drugs for Osteoarthritis Pain Revenue, 2022-2027
6.2.3 By Region - Global Drugs for Osteoarthritis Pain Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Drugs for Osteoarthritis Pain Revenue, 2016-2027
6.3.2 US Drugs for Osteoarthritis Pain Market Size, 2016-2027
6.3.3 Canada Drugs for Osteoarthritis Pain Market Size, 2016-2027
6.3.4 Mexico Drugs for Osteoarthritis Pain Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Drugs for Osteoarthritis Pain Revenue, 2016-2027
6.4.2 Germany Drugs for Osteoarthritis Pain Market Size, 2016-2027
6.4.3 France Drugs for Osteoarthritis Pain Market Size, 2016-2027
6.4.4 U.K. Drugs for Osteoarthritis Pain Market Size, 2016-2027
6.4.5 Italy Drugs for Osteoarthritis Pain Market Size, 2016-2027
6.4.6 Russia Drugs for Osteoarthritis Pain Market Size, 2016-2027
6.4.7 Nordic Countries Drugs for Osteoarthritis Pain Market Size, 2016-2027
6.4.8 Benelux Drugs for Osteoarthritis Pain Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Drugs for Osteoarthritis Pain Revenue, 2016-2027
6.5.2 China Drugs for Osteoarthritis Pain Market Size, 2016-2027
6.5.3 Japan Drugs for Osteoarthritis Pain Market Size, 2016-2027
6.5.4 South Korea Drugs for Osteoarthritis Pain Market Size, 2016-2027
6.5.5 Southeast Asia Drugs for Osteoarthritis Pain Market Size, 2016-2027
6.5.6 India Drugs for Osteoarthritis Pain Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Drugs for Osteoarthritis Pain Revenue, 2016-2027
6.6.2 Brazil Drugs for Osteoarthritis Pain Market Size, 2016-2027
6.6.3 Argentina Drugs for Osteoarthritis Pain Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Drugs for Osteoarthritis Pain Revenue, 2016-2027
6.7.2 Turkey Drugs for Osteoarthritis Pain Market Size, 2016-2027
6.7.3 Israel Drugs for Osteoarthritis Pain Market Size, 2016-2027
6.7.4 Saudi Arabia Drugs for Osteoarthritis Pain Market Size, 2016-2027
6.7.5 UAE Drugs for Osteoarthritis Pain Market Size, 2016-2027
7 Players Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Drugs for Osteoarthritis Pain Major Product Offerings
7.1.4 Pfizer Drugs for Osteoarthritis Pain Revenue in Global (2016-2021)
7.1.5 Pfizer Key News
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Corporate Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Drugs for Osteoarthritis Pain Major Product Offerings
7.2.4 Johnson & Johnson Drugs for Osteoarthritis Pain Revenue in Global (2016-2021)
7.2.5 Johnson & Johnson Key News
7.3 GlaxoSmithKline
7.3.1 GlaxoSmithKline Corporate Summary
7.3.2 GlaxoSmithKline Business Overview
7.3.3 GlaxoSmithKline Drugs for Osteoarthritis Pain Major Product Offerings
7.3.4 GlaxoSmithKline Drugs for Osteoarthritis Pain Revenue in Global (2016-2021)
7.3.5 GlaxoSmithKline Key News
7.4 Bayer
7.4.1 Bayer Corporate Summary
7.4.2 Bayer Business Overview
7.4.3 Bayer Drugs for Osteoarthritis Pain Major Product Offerings
7.4.4 Bayer Drugs for Osteoarthritis Pain Revenue in Global (2016-2021)
7.4.5 Bayer Key News
7.5 Eli Lilly
7.5.1 Eli Lilly Corporate Summary
7.5.2 Eli Lilly Business Overview
7.5.3 Eli Lilly Drugs for Osteoarthritis Pain Major Product Offerings
7.5.4 Eli Lilly Drugs for Osteoarthritis Pain Revenue in Global (2016-2021)
7.5.5 Eli Lilly Key News
7.6 Novartis
7.6.1 Novartis Corporate Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis Drugs for Osteoarthritis Pain Major Product Offerings
7.6.4 Novartis Drugs for Osteoarthritis Pain Revenue in Global (2016-2021)
7.6.5 Novartis Key News
7.7 Sanofi
7.7.1 Sanofi Corporate Summary
7.7.2 Sanofi Business Overview
7.7.3 Sanofi Drugs for Osteoarthritis Pain Major Product Offerings
7.4.4 Sanofi Drugs for Osteoarthritis Pain Revenue in Global (2016-2021)
7.7.5 Sanofi Key News
7.8 Horizon Pharma
7.8.1 Horizon Pharma Corporate Summary
7.8.2 Horizon Pharma Business Overview
7.8.3 Horizon Pharma Drugs for Osteoarthritis Pain Major Product Offerings
7.8.4 Horizon Pharma Drugs for Osteoarthritis Pain Revenue in Global (2016-2021)
7.8.5 Horizon Pharma Key News
7.9 Abbott
7.9.1 Abbott Corporate Summary
7.9.2 Abbott Business Overview
7.9.3 Abbott Drugs for Osteoarthritis Pain Major Product Offerings
7.9.4 Abbott Drugs for Osteoarthritis Pain Revenue in Global (2016-2021)
7.9.5 Abbott Key News
7.10 Mylan
7.10.1 Mylan Corporate Summary
7.10.2 Mylan Business Overview
7.10.3 Mylan Drugs for Osteoarthritis Pain Major Product Offerings
7.10.4 Mylan Drugs for Osteoarthritis Pain Revenue in Global (2016-2021)
7.10.5 Mylan Key News
7.11 Daiichi Sankyo
7.11.1 Daiichi Sankyo Corporate Summary
7.11.2 Daiichi Sankyo Business Overview
7.11.3 Daiichi Sankyo Drugs for Osteoarthritis Pain Major Product Offerings
7.11.4 Daiichi Sankyo Drugs for Osteoarthritis Pain Revenue in Global (2016-2021)
7.11.5 Daiichi Sankyo Key News
7.12 TEVA
7.12.1 TEVA Corporate Summary
7.12.2 TEVA Business Overview
7.12.3 TEVA Drugs for Osteoarthritis Pain Major Product Offerings
7.12.4 TEVA Drugs for Osteoarthritis Pain Revenue in Global (2016-2021)
7.12.5 TEVA Key News
7.13 Almatica Pharma
7.13.1 Almatica Pharma Corporate Summary
7.13.2 Almatica Pharma Business Overview
7.13.3 Almatica Pharma Drugs for Osteoarthritis Pain Major Product Offerings
7.13.4 Almatica Pharma Drugs for Osteoarthritis Pain Revenue in Global (2016-2021)
7.13.5 Almatica Pharma Key News
7.14 Astellas Pharma
7.14.1 Astellas Pharma Corporate Summary
7.14.2 Astellas Pharma Business Overview
7.14.3 Astellas Pharma Drugs for Osteoarthritis Pain Major Product Offerings
7.14.4 Astellas Pharma Drugs for Osteoarthritis Pain Revenue in Global (2016-2021)
7.14.5 Astellas Pharma Key News
7.15 Tide Pharmaceutical
7.15.1 Tide Pharmaceutical Corporate Summary
7.15.2 Tide Pharmaceutical Business Overview
7.15.3 Tide Pharmaceutical Drugs for Osteoarthritis Pain Major Product Offerings
7.15.4 Tide Pharmaceutical Drugs for Osteoarthritis Pain Revenue in Global (2016-2021)
7.15.5 Tide Pharmaceutical Key News
7.16 Iroko Pharmaceuticals
7.16.1 Iroko Pharmaceuticals Corporate Summary
7.16.2 Iroko Pharmaceuticals Business Overview
7.16.3 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Major Product Offerings
7.16.4 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Revenue in Global (2016-2021)
7.16.5 Iroko Pharmaceuticals Key News
7.17 Hengrui Pharmaceutical
7.17.1 Hengrui Pharmaceutical Corporate Summary
7.17.2 Hengrui Pharmaceutical Business Overview
7.17.3 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Major Product Offerings
7.17.4 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Revenue in Global (2016-2021)
7.17.5 Hengrui Pharmaceutical Key News
7.18 Abiogen Pharma
7.18.1 Abiogen Pharma Corporate Summary
7.18.2 Abiogen Pharma Business Overview
7.18.3 Abiogen Pharma Drugs for Osteoarthritis Pain Major Product Offerings
7.18.4 Abiogen Pharma Drugs for Osteoarthritis Pain Revenue in Global (2016-2021)
7.18.5 Abiogen Pharma Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Drugs for Osteoarthritis Pain Market Opportunities & Trends in Global Market
Table 2. Drugs for Osteoarthritis Pain Market Drivers in Global Market
Table 3. Drugs for Osteoarthritis Pain Market Restraints in Global Market
Table 4. Key Players of Drugs for Osteoarthritis Pain in Global Market
Table 5. Top Drugs for Osteoarthritis Pain Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Drugs for Osteoarthritis Pain Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Drugs for Osteoarthritis Pain Revenue Share by Companies, 2016-2021
Table 8. Global Companies Drugs for Osteoarthritis Pain Product Type
Table 9. List of Global Tier 1 Drugs for Osteoarthritis Pain Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Drugs for Osteoarthritis Pain Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Drugs for Osteoarthritis Pain Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Drugs for Osteoarthritis Pain Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Drugs for Osteoarthritis Pain Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Drugs for Osteoarthritis Pain Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Drugs for Osteoarthritis Pain Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Drugs for Osteoarthritis Pain Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2022-2027
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Drugs for Osteoarthritis Pain Product Offerings
Table 32. Pfizer Drugs for Osteoarthritis Pain Revenue (US$, Mn), (2016-2021)
Table 33. Johnson & Johnson Corporate Summary
Table 34. Johnson & Johnson Drugs for Osteoarthritis Pain Product Offerings
Table 35. Johnson & Johnson Drugs for Osteoarthritis Pain Revenue (US$, Mn), (2016-2021)
Table 36. GlaxoSmithKline Corporate Summary
Table 37. GlaxoSmithKline Drugs for Osteoarthritis Pain Product Offerings
Table 38. GlaxoSmithKline Drugs for Osteoarthritis Pain Revenue (US$, Mn), (2016-2021)
Table 39. Bayer Corporate Summary
Table 40. Bayer Drugs for Osteoarthritis Pain Product Offerings
Table 41. Bayer Drugs for Osteoarthritis Pain Revenue (US$, Mn), (2016-2021)
Table 42. Eli Lilly Corporate Summary
Table 43. Eli Lilly Drugs for Osteoarthritis Pain Product Offerings
Table 44. Eli Lilly Drugs for Osteoarthritis Pain Revenue (US$, Mn), (2016-2021)
Table 45. Novartis Corporate Summary
Table 46. Novartis Drugs for Osteoarthritis Pain Product Offerings
Table 47. Novartis Drugs for Osteoarthritis Pain Revenue (US$, Mn), (2016-2021)
Table 48. Sanofi Corporate Summary
Table 49. Sanofi Drugs for Osteoarthritis Pain Product Offerings
Table 50. Sanofi Drugs for Osteoarthritis Pain Revenue (US$, Mn), (2016-2021)
Table 51. Horizon Pharma Corporate Summary
Table 52. Horizon Pharma Drugs for Osteoarthritis Pain Product Offerings
Table 53. Horizon Pharma Drugs for Osteoarthritis Pain Revenue (US$, Mn), (2016-2021)
Table 54. Abbott Corporate Summary
Table 55. Abbott Drugs for Osteoarthritis Pain Product Offerings
Table 56. Abbott Drugs for Osteoarthritis Pain Revenue (US$, Mn), (2016-2021)
Table 57. Mylan Corporate Summary
Table 58. Mylan Drugs for Osteoarthritis Pain Product Offerings
Table 59. Mylan Drugs for Osteoarthritis Pain Revenue (US$, Mn), (2016-2021)
Table 60. Daiichi Sankyo Corporate Summary
Table 61. Daiichi Sankyo Drugs for Osteoarthritis Pain Product Offerings
Table 62. Daiichi Sankyo Drugs for Osteoarthritis Pain Revenue (US$, Mn), (2016-2021)
Table 63. TEVA Corporate Summary
Table 64. TEVA Drugs for Osteoarthritis Pain Product Offerings
Table 65. TEVA Drugs for Osteoarthritis Pain Revenue (US$, Mn), (2016-2021)
Table 66. Almatica Pharma Corporate Summary
Table 67. Almatica Pharma Drugs for Osteoarthritis Pain Product Offerings
Table 68. Almatica Pharma Drugs for Osteoarthritis Pain Revenue (US$, Mn), (2016-2021)
Table 69. Astellas Pharma Corporate Summary
Table 70. Astellas Pharma Drugs for Osteoarthritis Pain Product Offerings
Table 71. Astellas Pharma Drugs for Osteoarthritis Pain Revenue (US$, Mn), (2016-2021)
Table 72. Tide Pharmaceutical Corporate Summary
Table 73. Tide Pharmaceutical Drugs for Osteoarthritis Pain Product Offerings
Table 74. Tide Pharmaceutical Drugs for Osteoarthritis Pain Revenue (US$, Mn), (2016-2021)
Table 75. Iroko Pharmaceuticals Corporate Summary
Table 76. Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Product Offerings
Table 77. Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Revenue (US$, Mn), (2016-2021)
Table 78. Hengrui Pharmaceutical Corporate Summary
Table 79. Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Product Offerings
Table 80. Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Revenue (US$, Mn), (2016-2021)
Table 81. Abiogen Pharma Corporate Summary
Table 82. Abiogen Pharma Drugs for Osteoarthritis Pain Product Offerings
Table 83. Abiogen Pharma Drugs for Osteoarthritis Pain Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Drugs for Osteoarthritis Pain Segment by Type
Figure 2. Drugs for Osteoarthritis Pain Segment by Application
Figure 3. Global Drugs for Osteoarthritis Pain Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Drugs for Osteoarthritis Pain Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Drugs for Osteoarthritis Pain Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Drugs for Osteoarthritis Pain Revenue in 2020
Figure 8. By Type - Global Drugs for Osteoarthritis Pain Revenue Market Share, 2016-2027
Figure 9. By Application - Global Drugs for Osteoarthritis Pain Revenue Market Share, 2016-2027
Figure 10. By Region - Global Drugs for Osteoarthritis Pain Revenue Market Share, 2016-2027
Figure 11. By Country - North America Drugs for Osteoarthritis Pain Revenue Market Share, 2016-2027
Figure 12. US Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Drugs for Osteoarthritis Pain Revenue Market Share, 2016-2027
Figure 16. Germany Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 17. France Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Drugs for Osteoarthritis Pain Revenue Market Share, 2016-2027
Figure 24. China Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 28. India Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Drugs for Osteoarthritis Pain Revenue Market Share, 2016-2027
Figure 30. Brazil Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Drugs for Osteoarthritis Pain Revenue Market Share, 2016-2027
Figure 33. Turkey Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Drugs for Osteoarthritis Pain Revenue, (US$, Mn), 2016-2027
Figure 37. Pfizer Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Johnson & Johnson Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. GlaxoSmithKline Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Bayer Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Eli Lilly Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Novartis Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Sanofi Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Horizon Pharma Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Abbott Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Mylan Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Daiichi Sankyo Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. TEVA Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Almatica Pharma Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. Astellas Pharma Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 51. Tide Pharmaceutical Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 52. Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 53. Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 54. Abiogen Pharma Drugs for Osteoarthritis Pain Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs